# A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.

> **NCT01789099** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ultimovacs ASA** · enrollment: 18 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** UV1 synthetic peptide vaccine and GM-CSF

## Key facts

- **NCT ID:** NCT01789099
- **Lead sponsor:** Ultimovacs ASA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-08
- **Primary completion:** 2016-02-29
- **Final completion:** 2020-06-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01789099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01789099, "A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01789099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*